Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,939
in 1 filing, $42K under 10b5-1 plans

Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. de Verneuil Vanina −$42K EVP, General Counsel, Corp Sec sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2022-08-09 Virgin Herbert EVP, Research & CSO Option exercise +70,177 $1.53 $107K 254,584
2022-08-09 Virgin Herbert EVP, Research & CSO Option exercise +7,916 $10.40 $82K 262,500
2022-08-09 Virgin Herbert EVP, Research & CSO Option exercise · Stock Option (Right to Buy) −70,177 140,328
2022-08-09 Virgin Herbert EVP, Research & CSO Option exercise · Stock Option (Right to Buy) −7,916 125,416
2022-03-10 Virgin Herbert EVP, Research & CSO Option exercise +9,000 $1.53 $14K 184,407
2022-03-10 Virgin Herbert EVP, Research & CSO Option exercise · Stock Option (Right to Buy) −9,000 210,505
2022-02-22 Virgin Herbert EVP, Research & CSO Grant or award +70,000 175,407
2022-02-22 Virgin Herbert EVP, Research & CSO Option exercise +1,375 $1.53 $2K 176,782
2022-02-22 Virgin Herbert EVP, Research & CSO Sale −1,375 $30.00 $41K 175,407
2022-02-22 Virgin Herbert EVP, Research & CSO Option exercise · Stock Option (Right to Buy) −1,375 219,505
2022-02-22 Virgin Herbert EVP, Research & CSO Grant or award · Stock Option (Right to Buy) +70,000 70,000
2022-02-17 Virgin Herbert EVP, Research & CSO Sale −2,293 $31.93 $73K 105,407
2022-02-08 Virgin Herbert EVP, Research & CSO Option exercise +1,375 $1.53 $2K 109,075
2022-02-08 Virgin Herbert EVP, Research & CSO Sale −1,375 $33.94 $47K 107,700
2022-02-08 Virgin Herbert EVP, Research & CSO Option exercise · Stock Option (Right to Buy) −1,375 220,880
2022-01-25 Virgin Herbert EVP, Research & CSO Option exercise +1,375 $1.53 $2K 109,075
2022-01-25 Virgin Herbert EVP, Research & CSO Sale −1,375 $32.46 $45K 107,700
2022-01-25 Virgin Herbert EVP, Research & CSO Option exercise · Stock Option (Right to Buy) −1,375 222,255
2022-01-11 Virgin Herbert EVP, Research & CSO Option exercise +1,375 $1.53 $2K 109,075
2022-01-11 Virgin Herbert EVP, Research & CSO Sale −1,375 $35.10 $48K 107,700

Page 1 of 10 · 198 trades